Results 101 to 110 of about 26,501 (228)

Transarterial chemoembolization and bland embolization for hepatocellular carcinoma

World Journal of Gastroenterology, 2014
Transarterial chemoembolization (TACE) is the first line treatment for patients with intermediate stage hepatocellular carcinoma but is also increasingly being used for patients on the transplant waiting list to prevent further tumor growth. Despite its widespread use, TACE remains an unstandardized procedure, with variation in type and size of ...
Emmanuel A, Tsochatzis, Evangelia, Fatourou, James, O'Beirne, Tim, Meyer, Andrew K, Burroughs   +4 more
openaire   +2 more sources

Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma

Gastroenterology Research and Practice, 2016
Background. Transarterial chemoembolization alone or in association with radiofrequency ablation is an effective bridging strategy for patients with hepatocellular carcinoma awaiting for a liver transplant.
Marcio F. Chedid, Leandro A. Scaffaro, Aljamir D. Chedid, Antonio C. Maciel, Carlos Thadeu S. Cerski, Matheus J. Reis, Tomaz J. M. Grezzana-Filho, Alexandre de Araujo, Ian Leipnitz, Cleber D. P. Kruel, Mario R. Alvares-da-Silva, Cleber R. P. Kruel   +11 more
doaj   +1 more source

Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient

International Journal of Gerontology, 2014
Tumor lysis syndrome (TLS) is rarely induces after Transarterial chemoembolization for hepatocellular carcinoma. We present a patient with a large hepatocellular carcinoma who received twice transarterial embolization (TAE).
Hsaing-Hung Lin, Wei-Ho Chang, Horng-Yuan Wang, Ming-Jen Chen, Shou-Chuan Shih   +4 more
doaj   +1 more source

Transarterial chemoembolization for hepatocellular carcinoma

Asian Medical Journal and Alternative Medicine, 2014
Hepatocellular carcinoma (HCC) is common cancer in the world. Hepatitis B/C or alcoholic cirrhosis is usuallyunderlying condition. Surgical resection is curative treatment for small HCC, however most patients usually present whenadvanced or inoperable disease.
openaire   +1 more source

Long-term survival in a patient with unresectable liver metastases from uveal melanoma treated with transarterial chemoembolization with irinotecan eluting beads – case report and review of literature [PDF]

, 2017
Introduction : Treatment of unresectable liver metastases (LM) from uveal melanoma (UM) remains a major clinical challenge. Systemic chemotherapy and chemoimmunotherapy regimens extrapolated from cutaneous melanoma are considered to be ineffective in ...
Mikołaj Nawrocki, Katarzyna Stanisławska, Honorata Stadnik, Michał Drews, Robert Juszkat, Katarzyna Ramlau-Piątek   +5 more
core   +1 more source

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

, 2015
Ji Hye Jang, Jin-Woo Lee, Ji Taek Hong, Young-Joo JinDivision of Gastroenterology and Hepatology, Inha University School of Medicine and Hospital, Incheon, Republic of Korea Abstract: Transarterial chemoembolization (TACE) is the standard treatment for ...
Hong JT, Jin YJ, Jang JH, Lee JW
core  

Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization

, 2017
Hypoxia is known to be important in the generation and maintenance of stemness; however, its clinical significance is yet to be determined in human hepatocellular carcinoma. The expression of stemness (K19, EpCAM) and hypoxia (carbonic anhydrase-IX (CAIX)
최기홍, 박영년, 고명주, 남지해, 유정은   +4 more
core   +1 more source

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

, 2017
Waleed Fateen,1,2 Farooq Khan,1 Richard J O’Neill,3 Martin W James,1 Stephen D Ryder,1 Guruprasad P Aithal1,2 1NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, 2Nottingham Digestive
James MW, Khan F, Fateen W, O’Neill RJ, Aithal GP, Ryder SD   +5 more
core  

Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?

, 2013
PURPOSE: To evaluate the per-nodule efficacy of superselective transarterial chemoembolization of hepatocellular carcinomas (HCCs). MATERIALS AND METHODS: From 2006-2009, 271 cirrhotic patients with 635 nodules underwent a first superselective ...
Forlani L, Bologna Liver Oncology Group, PISCAGLIA, FABIO, Giampalma E, Mosconi C, TREVISANI, FRANCO, Renzulli M, GOLFIERI, RITA, BOLONDI, LUIGI   +8 more
core   +1 more source

An Evidence-Based Multidisciplinary Approach to the Management of Hepatocellular Carcinoma (HCC): The Alberta HCC Algorithm

Canadian Journal of Gastroenterology, 2010
Hepatocellular carcinoma (HCC) is one of only a few malignancies with an increasing incidence in North America. Because the vast majority of HCCs occur in the setting of a cirrhotic liver, management of this malignancy is best performed in a ...
Kelly W Burak, Norman M Kneteman
doaj   +1 more source